Labcorp, US50540R4092

Labcorp stock heads into the open after a modest September 8 move

Published on 09/09/2026 at 08:14 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 8, 2026, Labcorp stock finished near its recent range on the New York Stock Exchange, with a small percent change and trading volume consistent with broader market weakness. Oil-driven pressure on US equities frames today for Labcorp stock.

Modernes Diagnostiklabor mit Technikern in weißen Kitteln an automatisierten Analysegeräten
Labcorp (ISIN US50540R4092) betreibt moderne klinische Labore mit Technikern und automatisierten Diagnosegeräten hinter Glasfassaden, Illustration mit AI erstellt.

Labcorp stock closed at USD 212.40 on the New York Stock Exchange on September 8, 2026, up 0.3 percent from the prior session. This move came as US equities generally slipped under rising oil prices, leaving the shares slightly ahead of the broader market decline.

September 8, 2026 in numbers

Labcorp Holdings Inc. (ISIN US50540R4092, NYSE: LH) ended the September 8, 2026 session at USD 212.40 after trading between an intraday low of USD 209.20 and a high of USD 213.80, keeping the close well within its 52 week range. Trading volume reached about 620,000 shares, close to recent averages for the stock. The prior close was USD 211.75, so the latest session added USD 0.65 per share and produced the 0.3 percent gain.

In the same session, the S&P 500 lost roughly 0.4 percent, underscoring that Labcorp modestly outperformed the broad US market on September 8, 2026. As Pittsburgh Post-Gazette reported on September 8, 2026, US stocks fell on their return from a three day weekend as rising oil prices weighed on sentiment, a backdrop that also shaped trading in health care names like Labcorp.

Events around today for Labcorp

According to the investor relations overview at Labcorp, the company is slated to participate in the Morgan Stanley 24th Annual Global Healthcare Conference and to host a 2026 Investor Day, events that typically draw institutional attention to strategy and capital allocation, though specific dates and times are set outside the immediate week around September 9, 2026. The same overview highlights the Q2 2026 Labcorp Holdings Inc. earnings conference call, which recently provided updated financial guidance and performance commentary, and that communication continues to inform investor expectations heading into today’s session.

Disclaimer...

en | US50540R4092 | LABCORP | boerse | 70073477 | bgmi